首页|浅谈纳米晶药物的药学研究与评价

浅谈纳米晶药物的药学研究与评价

扫码查看
纳米晶药物可显著改善药物的溶解度和生物利用度.目前已有多个纳米晶药物在全球上市,但国内外监管机构尚未针对纳米晶药物形成明确、统一的监管评估方案.该文对国内外纳米晶药物的监管及上市情况进行了介绍,从纳米晶药物的原料药、辅料、生产工艺、质量研究与控制、包材与稳定性等方面,对纳米晶药物的药学研究与评价进行探讨,并结合案例进行分析,以期为纳米晶药物的药学研究与评价提供参考.
A Brief Analysis of Pharmaceutical Research and Evaluation of Nanocrystal Pharmaceutical Products
Nanocrystal pharmaceutical products can significantly improve drug solubility and bioavailability.Several products have been marketed globally,but domestic and foreign regulatory agencies have not yet formed a clear and unified regulatory assessment program for them.This review introduces the regulation and listing of some nanocrystal pharmaceutical products marketed at home and abroad,discusses the pharmaceutical research and evaluation from the aspects of API,excipients,production process,quality research and control,packaging materials and stability,and analyzes them with case studies,in order to provide a reference for the pharmaceutical research and evaluation of nanocrystal pharmaceutical products.

nanocrystalnanomedicinepharmaceutical researchevaluation

杨柳、章俊麟、石勇平、许真玉

展开 >

国家药品监督管理局药品审评中心,北京 100076

纳米晶 纳米药物 药学研究 评价

2024

中国医药工业杂志
上海医药工业研究院,中国化学制药工业协会

中国医药工业杂志

CSTPCD
影响因子:0.487
ISSN:1001-8255
年,卷(期):2024.55(4)
  • 34